NEW YORK (GenomeWeb) – Pressure BioSciences said in its Form 10-Q filed with the US Securities and Exchange Commission on Friday that its revenues in Q1 2015 grew 9 percent year over year to $440,134 from $404,147. 

Product, services, and other revenues were down to $359,364 from $404,147 in Q1 2014, but grant revenues increased to $80,770 from zero in the year-ago quarter. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.